RYR2 and cardiac hypertrophy: Although RyR2 mutations that impair CaM regulation in cardiac pathologies have not yet been identified, our studies should help to understand the role of RyR2 regulation by CaM and CaMKII in cardiac hypertrophy and heart failure in humans.